Stevens Capital Management’s Charles River Laboratories CRL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2019
Q4 | – | Sell |
-3,316
| Closed | -$439K | – | 638 |
|
|
2019
Q3 | $439K | Buy |
+3,316
| New | +$439K | 0.04% | 379 |
|
|
2019
Q1 | – | Sell |
-5,412
| Closed | -$613K | – | 716 |
|
|
2018
Q4 | $613K | Buy |
+5,412
| New | +$613K | 0.03% | 464 |
|
|
2017
Q4 | – | Sell |
-36,563
| Closed | -$3.95M | – | 864 |
|
|
2017
Q3 | $3.95M | Buy |
36,563
+28,315
| +343% | +$3.06M | 0.15% | 192 |
|
|
2017
Q2 | $834K | Buy |
8,248
+2,503
| +44% | +$253K | 0.03% | 472 |
|
|
2017
Q1 | $517K | Buy |
+5,745
| New | +$517K | 0.02% | 569 |
|
|
2016
Q4 | – | Sell |
-11,063
| Closed | -$922K | – | 908 |
|
|
2016
Q3 | $922K | Buy |
+11,063
| New | +$922K | 0.04% | 443 |
|
|
2016
Q2 | – | Sell |
-10,330
| Closed | -$784K | – | 937 |
|
|
2016
Q1 | $784K | Buy |
+10,330
| New | +$784K | 0.03% | 478 |
|
|
2015
Q4 | – | Sell |
-9,481
| Closed | -$602K | – | 956 |
|
|
2015
Q3 | $602K | Sell |
9,481
-4,228
| -31% | -$268K | 0.03% | 484 |
|
|
2015
Q2 | $964K | Buy |
+13,709
| New | +$964K | 0.03% | 435 |
|
|
2015
Q1 | – | Sell |
-7,013
| Closed | -$446K | – | 1018 |
|
|
2014
Q4 | $446K | Buy |
+7,013
| New | +$446K | 0.02% | 610 |
|
|
2014
Q3 | – | Sell |
-32,599
| Closed | -$1.75M | – | 1035 |
|
|
2014
Q2 | $1.75M | Buy |
+32,599
| New | +$1.75M | 0.05% | 393 |
|
|
2013
Q4 | – | Sell |
-24,766
| Closed | -$1.15M | – | 1037 |
|
|
2013
Q3 | $1.15M | Sell |
24,766
-11,994
| -33% | -$555K | 0.03% | 453 |
|
|
2013
Q2 | $1.51M | Buy |
+36,760
| New | +$1.51M | 0.05% | 375 |
|